# APBA2

## Overview
The APBA2 gene encodes the protein amyloid beta precursor protein binding family A member 2, commonly referred to as Mint2 or X11β. Mint2 is a neuronal adaptor protein that plays a significant role in synaptic function and neurotransmitter release. It is characterized by a multi-domain structure, including a phosphotyrosine-binding (PTB) domain and two PDZ domains, which facilitate its interactions with other synaptic proteins such as neurexin-1α and syntaxin 1. These interactions are crucial for synaptic vesicle docking, fusion, and the polarized trafficking of proteins to the presynaptic membrane, processes vital for normal synapse formation and maintenance (Lin2019A). Mint2 is predominantly localized to the Golgi apparatus and is involved in the proteolytic processing of amyloid precursor protein (APP), a process central to Alzheimer's disease pathogenesis (Lin2019A). The gene's expression is primarily neuronal and is regulated at the transcriptional level (Hao2012Promoter).

## Structure
The APBA2 gene encodes the Mint2 protein, also known as X11β, which is a synaptic adaptor protein involved in neuronal signaling and synaptic function. Mint2 contains several important domains, including a phosphotyrosine-binding (PTB) domain and two PDZ domains, which are crucial for its interactions with other proteins, such as neurexin-1α (Nrxn1α) (Lin2019A). These domains facilitate the protein's role in excitatory synaptic transmission and are essential for its function in synapse formation and maintenance (Lin2019A).

The PDZ domains of Mint2 are particularly important for dimerization, as demonstrated by reduced binding in a mutant lacking these domains (Lin2019A). The N723S mutation in Mint2, associated with autism spectrum disorders, affects the stabilization and trafficking of Nrxn1α, although it does not disrupt the binding of Mint2 to Nrxn1α (Lin2019A).

APBA2 is subject to post-translational modifications, such as phosphorylation, and has multiple splice variant isoforms, which can influence its function and interactions. The genomic structure of APBA2 includes 15 exons and 14 intronic regions, with specific domains encoded by exons 7-15 (Hao2012Promoter).

## Function
The APBA2 gene encodes a neuronal adaptor protein known as Mint2, which plays a crucial role in synaptic function and neurotransmitter release. Mint2 is involved in the formation and function of synapses by interacting with neurexins and syntaxin 1, which are essential for synaptic vesicle docking and fusion (Peycheva2018Chromosomal). It functions as a mobile protein at the Golgi apparatus, controlling the polarized trafficking of Neurexin 1α (Nrxn1α) to the presynaptic membrane, a process vital for normal synapse formation (Lin2019A).

Mint2 is part of a family of neuronal adaptor proteins that includes MINTs 1-3, characterized by a multi-domain structure with a phosphotyrosine-binding (PTB) domain and two PDZ domains. These domains facilitate interactions with other proteins, influencing synaptic vesicle exocytosis and the proteolytic processing of amyloid precursor protein (APP), which is central to Alzheimer's disease pathogenesis (Lin2019A). The protein is predominantly localized to the Golgi and is involved in the polarized trafficking of axonal Nrxn1α, enhancing its surface levels and stability, which is crucial for synaptic function (Lin2019A). APBA2's activity is primarily neuronal, with its expression regulated at the transcriptional level (Hao2012Promoter).

## Clinical Significance
Mutations and alterations in the APBA2 gene have been implicated in several neurological conditions, including autism spectrum disorders (ASD) and intellectual disability (ID). A rare mutation, N723S, in the Mint2/APBA2 gene has been associated with ASD. This mutation disrupts the trafficking and stabilization of neurexin-1α (Nrxn1α), a protein crucial for synapse formation, leading to decreased synaptogenesis and impaired synaptic function (Lin2019A). The N723S mutation affects the stability and membrane trafficking of Nrxn1α, potentially contributing to ASD pathophysiology by impairing excitatory synaptic transmission (Lin2019A).

Duplications of the APBA2 gene have been linked to neuropsychiatric disorders, including early onset schizophrenia and autism. In a study involving a family with ID and epilepsy, a duplication in the 15q13.1 region encompassing APBA2 was identified, suggesting that overexpression of APBA2 might contribute to these clinical features (Peycheva2018Chromosomal). Additionally, APBA2 is part of the APP protein-protein interaction network, which is involved in Alzheimer's disease (AD) and Down syndrome (DS). Alterations in this network, including those involving APBA2, may contribute to the pathogenesis of AD and DS (Sharma2020Common).

## Interactions
APBA2, also known as MINT2, is a synaptic adaptor protein that participates in various protein interactions crucial for synaptic function. It interacts with neurexin-1α (Nrxn1α), a presynaptic cell-adhesion protein, through its PDZ domains. This interaction is essential for the stabilization and trafficking of Nrxn1α to the cell surface, which is critical for synapse formation and function (Lin2019A). The N723S mutation in APBA2 affects this interaction by disrupting the trafficking of Nrxn1α, leading to impaired synaptic formation and function (Lin2019A).

APBA2 also interacts with the amyloid precursor protein (APP) via its PTB domain, influencing APP processing, which is significant in Alzheimer's disease pathogenesis (Lin2019A). The X11 family of proteins, including APBA2, binds to the conserved YENPTY motif in the APP C terminus, affecting APP processing and amyloid β-protein (Aβ) production (Xie2005RNA). RNA interference studies have shown that silencing APBA2 reduces Aβ levels, although it does not significantly alter APP processing, suggesting a role in Aβ production independent of direct APP cleavage (Xie2005RNA). APBA2's interactions with other proteins, such as presenilin-1, may also influence APP trafficking and processing (Xie2005RNA).


## References


[1. (Peycheva2018Chromosomal) Valentina Peycheva, Kunka Kamenarova, Neviana Ivanova, Dimitar Stamatov, Daniela Avdjieva-Tzavella, Iliana Alexandrova, Sashka Zhelyazkova, Iliana Pacheva, Petya Dimova, Ivan Ivanov, Ivan Litvinenko, Veneta Bozhinova, Ivailo Tournev, Emil Simeonov, Vanyo Mitev, Albena Jordanova, and Radka Kaneva. Chromosomal microarray analysis of bulgarian patients with epilepsy and intellectual disability. Gene, 667:45–55, August 2018. URL: http://dx.doi.org/10.1016/j.gene.2018.05.015, doi:10.1016/j.gene.2018.05.015. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.gene.2018.05.015)

[2. (Sharma2020Common) Ayati Sharma, Alisha Chunduri, Asha Gopu, Christine Shatrowsky, Wim E. Crusio, and Anna Delprato. Common genetic signatures of alzheimer’s disease in down syndrome. F1000Research, 9:1299, November 2020. URL: http://dx.doi.org/10.12688/f1000research.27096.1, doi:10.12688/f1000research.27096.1. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.12688/f1000research.27096.1)

[3. (Hao2012Promoter) Yan Hao, Ka-Ho Chai, Declan M. McLoughlin, Ho Yin Edwin Chan, and Kwok-Fai Lau. Promoter characterization and genomic organization of the human x11β gene apba2. NeuroReport, 23(3):146–151, February 2012. URL: http://dx.doi.org/10.1097/wnr.0b013e32834f1934, doi:10.1097/wnr.0b013e32834f1934. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1097/wnr.0b013e32834f1934)

[4. (Xie2005RNA) Zhongcong Xie, Donna M. Romano, and Rudolph E. Tanzi. Rna interference-mediated silencing of x11α and x11β attenuates amyloid β-protein levels via differential effects on β-amyloid precursor protein processing. Journal of Biological Chemistry, 280(15):15413–15421, April 2005. URL: http://dx.doi.org/10.1074/jbc.M414353200, doi:10.1074/jbc.m414353200. This article has 58 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M414353200)

[5. (Lin2019A) Amy Y. Lin, Shawna Henry, Carsten Reissner, Christian Neupert, Connor Kenny, Markus Missler, Uwe Beffert, and Angela Ho. A rare autism-associated mint2/apba2 mutation disrupts neurexin trafficking and synaptic function. Scientific Reports, April 2019. URL: http://dx.doi.org/10.1038/s41598-019-42635-7, doi:10.1038/s41598-019-42635-7. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-019-42635-7)